Spire Wealth Management Lowers Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Spire Wealth Management cut its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 69.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,518 shares of the company's stock after selling 14,733 shares during the period. Spire Wealth Management's holdings in Church & Dwight were worth $683,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Capital Performance Advisors LLP purchased a new position in shares of Church & Dwight in the third quarter valued at approximately $27,000. Ashton Thomas Securities LLC purchased a new position in Church & Dwight in the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc boosted its position in Church & Dwight by 224.4% in the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company's stock valued at $28,000 after buying an additional 184 shares during the period. Venturi Wealth Management LLC grew its stake in shares of Church & Dwight by 44.8% in the third quarter. Venturi Wealth Management LLC now owns 559 shares of the company's stock worth $59,000 after acquiring an additional 173 shares in the last quarter. Finally, Kennebec Savings Bank purchased a new stake in shares of Church & Dwight during the third quarter worth $61,000. 86.60% of the stock is owned by hedge funds and other institutional investors.

Church & Dwight Stock Down 0.3 %

Shares of NYSE:CHD traded down $0.35 during mid-day trading on Friday, reaching $105.05. 855,138 shares of the stock were exchanged, compared to its average volume of 1,640,525. The stock's 50 day simple moving average is $105.87 and its 200-day simple moving average is $104.33. Church & Dwight Co., Inc. has a one year low of $96.09 and a one year high of $113.50. The company has a market cap of $25.74 billion, a P/E ratio of 44.32, a P/E/G ratio of 3.35 and a beta of 0.59. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51.

Church & Dwight (NYSE:CHD - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same quarter in the previous year, the company earned $0.65 earnings per share. As a group, equities research analysts predict that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be issued a $0.295 dividend. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. This represents a $1.18 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Friday, February 14th. Church & Dwight's dividend payout ratio (DPR) is currently 47.68%.

Insider Activity

In related news, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the firm's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $106.11, for a total transaction of $1,061,100.00. Following the sale, the director now owns 32,500 shares of the company's stock, valued at $3,448,575. This trade represents a 23.53 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Bradley C. Irwin sold 13,200 shares of the company's stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $107.44, for a total value of $1,418,208.00. Following the completion of the transaction, the director now directly owns 37,169 shares of the company's stock, valued at $3,993,437.36. This represents a 26.21 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 115,622 shares of company stock worth $12,842,559. 2.00% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CHD. Barclays lifted their price target on shares of Church & Dwight from $90.00 to $93.00 and gave the stock an "underweight" rating in a research note on Tuesday. Truist Financial boosted their target price on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Monday, February 3rd. Stifel Nicolaus raised their price target on Church & Dwight from $103.00 to $105.00 and gave the company a "hold" rating in a research note on Monday, February 3rd. Piper Sandler lowered their price objective on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Church & Dwight from $114.00 to $115.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, Church & Dwight has an average rating of "Hold" and a consensus target price of $111.53.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.